Filing Details

Accession Number:
0001144204-15-057713
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-01 16:55:17
Reporting Period:
2015-09-30
Filing Date:
2015-10-01
Accepted Time:
2015-10-01 16:55:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910267 Titan Pharmaceuticals Inc TTNP.OB Biological Products, (No Disgnostic Substances) (2836) 943171940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180755 Sunil Bhonsle 400 Oyster Point Blvd., Suite 505
S San Francisco CA 94080
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-30 500 $3.98 90,774 No 4 P Direct
Common Stock Acquisiton 2015-10-01 200 $3.99 90,974 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 54,684 Indirect By Family Trust
Footnotes
  1. The reporting person serves as trustee of the family trust.